Pharmacology  ·  Local Anesthetics

Chemistry, Pharmacokinetics, and Individual Agents

Amides vs. esters, pharmacokinetic determinants, and high-yield agent profiles


Amide Class
Amide Local Anesthetics
  • Linkage: amide bond (-NH-CO-)
  • Metabolism: liver (hepatic enzymes)
  • Mnemonic: "i" before -caine (lidocaine, bupivacaine, ropivacaine)
  • True allergy: extremely rare
  • Most modern agents are amides
Ester Class
Ester Local Anesthetics
  • Linkage: ester bond (-CO-O-)
  • Metabolism: plasma pseudocholinesterase
  • Allergy metabolite: para-aminobenzoic acid
  • Generally shorter duration
  • Examples: cocaine, procaine, chloroprocaine, tetracaine, benzocaine
Cross-Reactivity Rule
No cross-reactivity between amides and esters. Ester allergy is due to para-aminobenzoic acid metabolite. Amide reactions often due to methylparaben preservative in multi-dose vials — use preservative-free formulations. Safe to substitute across classes.

Three Key Properties
What Governs Potency, Duration, and Onset
Property Effect High example Low example
Lipid solubility Higher = more potent, longer duration Bupivacaine Procaine
Protein binding Higher = longer duration Bupivacaine (~95%) Chloroprocaine
pKa near 7.4 More un-ionized at tissue pH = faster onset Lidocaine (7.9) Bupivacaine (8.1)

Amide — Most Versatile
Lidocaine
  • Intermediate duration and potency
  • Most widely used local anesthetic
  • Also Class Ib antiarrhythmic — sodium channel blockade in ventricular myocardium
  • Used for infiltration, nerve blocks, epidural, spinal, topical, intravenous regional
Amide — Cardiotoxic
Bupivacaine
  • Long duration, high protein binding (~95%)
  • Preferred for epidural labor analgesia
  • Cardiotoxic: "fast in, slow out" from cardiac sodium channels — cardiac arrest very difficult to resuscitate
  • Never use for intravenous regional anesthesia
Amide — Safer Alternative
Ropivacaine
  • Long duration, similar to bupivacaine
  • Less cardiotoxic than bupivacaine
  • More motor-sparing at lower concentrations
  • Preferred in obstetric epidurals where long duration needed
Amide — Methemoglobinemia
Prilocaine
  • Causes methemoglobinemia via metabolite ortho-toluidine
  • Component of EMLA cream (with lidocaine) for topical skin anesthesia
  • Risk clinically relevant in young infants
Ester — Unique Vasoconstrictor
Cocaine
  • Only local anesthetic that causes vasoconstriction
  • Blocks norepinephrine and dopamine reuptake
  • Topical use only (nasal and pharyngeal procedures)
  • Schedule II — high abuse potential
Ester — Topical / Methemoglobinemia
Benzocaine
  • Topical use only — insoluble for injection
  • Throat sprays, endoscopy topical anesthesia
  • Causes methemoglobinemia with excessive use
  • With prilocaine: two agents most associated with drug-induced methemoglobinemia in this class

Suggested References

Author / OrganizationTitleSource
Katzung BG, ed.Basic and Clinical Pharmacology. 15th ed.McGraw-Hill; 2021
Brunton LL, Knollmann BC, eds.Goodman & Gilman's The Pharmacological Basis of Therapeutics. 14th ed.McGraw-Hill; 2023
Butterworth JF 4th, Strichartz GRMolecular mechanisms of local anesthesia: a reviewAnesthesiology. 1990;72(4):711–734
Covino BG, Wildsmith JAWClinical pharmacology of local anesthetic agents. In: Cousins MJ, Bridenbaugh PO, eds. Neural Blockade in Clinical Anesthesia and Management of Pain. 3rd ed.Philadelphia: Lippincott-Raven; 1998:97–128
Lutfallah SC, Brown E, Spillers NJ, et al.Topical cocaine hydrochloride nasal solution: anesthetic and surgical considerationsCureus. 2023;15(8):e42804
Lofstrom JB1984 Labat Lecture: The effect of local anesthetics on the peripheral vasculatureReg Anesth. 1992;17(1):1–11
Tanaka M, Nishikawa TChloroprocaine vs lidocaine in epidural anesthesia for elective surgery: a comparative studyActa Anaesthesiol Scand. 1994;38(2):166–170
Ash-Bernal R, Wise R, Wright SMAcquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitalsMedicine (Baltimore). 2004;83(5):265–273
Freedman JM, Li DK, Drasner K, et al.Transient neurologic symptoms after spinal anesthesia: an epidemiologic study of 1,863 patientsAnesthesiology. 1998;89(3):633–641
Rosenberg PH, Veering BT, Urmey WFMaximum recommended doses of local anesthetics: a multifactorial conceptReg Anesth Pain Med. 2004;29(6):564–575
Camorcia M, Capogna G, Berritta C, Columb MOThe relative potencies for motor block after intrathecal ropivacaine, levobupivacaine, and bupivacaineAnesth Analg. 2007;104(4):904–907
Clarkson CW, Hondeghem LMMechanism for bupivacaine depression of cardiac conduction: fast block of sodium channels during the action potential with slow recovery from block during diastoleAnesthesiology. 1985;62(4):396–405
Leone S, Di Cianni S, Casati A, Fanelli GPharmacology, toxicology, and clinical use of new long acting local anesthetics, ropivacaine and levobupivacaineActa Biomed. 2008;79(2):92–105
Eisenach JC, De Kock M, Klimscha WAlpha(2)-adrenergic agonists for regional anesthesia: a clinical review of clonidine (1984–1995)Anesthesiology. 1996;85(3):655–674
DiFazio CA, Carron H, Grosslight KR, Moscicki JC, Bolding WR, Johns RAComparison of pH-adjusted lidocaine solutions for epidural anesthesiaAnesth Analg. 1986;65(7):760–764
Pehora C, Pearson AM, Kaushal A, Crawford MW, Johnston BDexamethasone as an adjuvant to peripheral nerve blockCochrane Database Syst Rev. 2017;11:CD011770